BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25120755)

  • 1. Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.
    Tang Z; Xia C; Huang R; Li X; Wang WC; Guo W; Duan L; Luo W; Cao D; Luo DX
    Int J Clin Exp Pathol; 2014; 7(7):3791-9. PubMed ID: 25120755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway.
    Luo DX; Huang MC; Ma J; Gao Z; Liao DF; Cao D
    Biochem J; 2011 Aug; 438(1):71-80. PubMed ID: 21585341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.
    Joshi A; Rajput S; Wang C; Ma J; Cao D
    Biol Chem; 2010 Dec; 391(12):1371-8. PubMed ID: 21087085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.
    Luo D; Bu Y; Ma J; Rajput S; He Y; Cai G; Liao DF; Cao D
    J Biol Chem; 2013 Dec; 288(51):36733-40. PubMed ID: 24217247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse.
    Rajak S; Gupta P; Anjum B; Raza S; Tewari A; Ghosh S; Tripathi M; Singh BK; Sinha RA
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166319. PubMed ID: 34954342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice.
    Wang X; Khoshaba R; Shen Y; Cao Y; Lin M; Zhu Y; Cao Z; Liao DF; Cao D
    Front Cell Dev Biol; 2021; 9():632805. PubMed ID: 33644071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.
    Wang C; Yan R; Luo D; Watabe K; Liao DF; Cao D
    J Biol Chem; 2009 Sep; 284(39):26742-8. PubMed ID: 19643728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
    Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
    Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.
    Shen Y; Ma J; Yan R; Ling H; Li X; Yang W; Gao J; Huang C; Bu Y; Cao Y; He Y; Wan L; Zu X; Liu J; Huang MC; Stenson WF; Liao DF; Cao D
    Clin Cancer Res; 2015 Mar; 21(6):1466-76. PubMed ID: 25538260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of AKR1B16, a novel mouse aldo-keto reductase.
    Giménez-Dejoz J; Weber S; Barski OA; Möller G; Adamski J; Parés X; Porté S; Farrés J
    Chem Biol Interact; 2017 Oct; 276():182-193. PubMed ID: 28322781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.
    Spite M; Baba SP; Ahmed Y; Barski OA; Nijhawan K; Petrash JM; Bhatnagar A; Srivastava S
    Biochem J; 2007 Jul; 405(1):95-105. PubMed ID: 17381426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A spontaneously immortalized Schwann cell line from aldose reductase-deficient mice as a useful tool for studying polyol pathway and aldehyde metabolism.
    Niimi N; Yako H; Takaku S; Kato H; Matsumoto T; Nishito Y; Watabe K; Ogasawara S; Mizukami H; Yagihashi S; Chung SK; Sango K
    J Neurochem; 2018 Mar; 144(6):710-722. PubMed ID: 29238976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib.
    Loeffler-Ragg J; Mueller D; Gamerith G; Auer T; Skvortsov S; Sarg B; Skvortsova I; Schmitz KJ; Martin HJ; Krugmann J; Alakus H; Maser E; Menzel J; Hilbe W; Lindner H; Schmid KW; Zwierzina H
    Mol Cancer Ther; 2009 Jul; 8(7):1995-2006. PubMed ID: 19567817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway.
    Demirkol Canlı S; Seza EG; Sheraj I; Gömçeli I; Turhan N; Carberry S; Prehn JHM; Güre AO; Banerjee S
    Carcinogenesis; 2020 Sep; 41(9):1219-1228. PubMed ID: 32628753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
    Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
    J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.
    Ruiz FX; Moro A; Gallego O; Ardèvol A; Rovira C; Petrash JM; Parés X; Farrés J
    Chem Biol Interact; 2011 May; 191(1-3):199-205. PubMed ID: 21329680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
    Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
    Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
    Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
    Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.